Inhibikase Therapeutics, Inc.

North America Legal Chronicle. August 2, 2024

Inhibikase Therapeutics’ $4 Million Common Stock Offering

By Laura Testa

McDermott Will & Emery represented Inhibikase Therapeutics in the transaction. Inhibikase Therapeutics, Inc. (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. February 15, 2023

Inhibikase Therapeutics’ $10 Million Direct Offering and Private Placements

By Laura Testa

McDermott Will & Emery represented Inhibikase Therapeutics, Inc. in the transaction. Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Kudu Investment Management’s Minority Investment in Revelation Partners

Rising Dragon Acquisition Corp.’s $57.5 Million Initial Public Offering

Bloomberg’s Expansion Lease with SL Green Realty

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

Eneva’s Acquisition of Tevisa Termelétrica Viana, Povoação Energia, Linhares Brasil Energia Participações, and 50% of Geradora de Energia do Maranhão

Summer Discovery’s Acquisition Of Oxford Summer Courses

Azelis’ Acquisition of Haarla

European Investment Bank’s €100 Million Digital Bonds Issuance

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Godavari Biorefineries Limited’s Initial Public Offering

Synthimed Labs’ Acquisition of Ind Swift Laboratories

Kakatiya Expressway’s Financing Round

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Inhibikase Therapeutics’ $4 Million Common Stock Offering

Standard 1 Year Membership Required

Inhibikase Therapeutics’ $10 Million Direct Offering and Private Placements

Standard 1 Year Membership Required